Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...
We recently published a list of Roth MKM’s AI & Non-AI Stocks To Be Cautious About: 15 Stocks Bank With $60 Billion Capital Raise Is Watching. In this article, we are going to take a look at ...
Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 37.32% ...
Fintel reports that on December 18, 2024, Roth MKM initiated coverage of U.S. Gold (LSE:0LHW) with a Buy recommendation. As of December 3, 2024, the average one-year price target for U.S. Gold is ...
Roth MKM analyst Matt Koranda maintained a Hold rating on AMMO (POWW – Research Report) today and set a price target of $1.75. The company’s ...
Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...